Comparison of Accuracy among Post-thrombolytic Symptomatic Intracerebral Hemorrhage Predictive Scores in Ischemic Stroke Patients in Khon Kaen Hospital.

  • Salintip Kunadison Khonkaen Hospital
  • Rubkhwan Nganwai
Keywords: predictive score, post-thrombolytic symptomatic intracerebral hemorrhage


     Introduction: Post-thrombolytic symptomatic intracerebral hemorrhage (sICH) is one of complications worsening outcome of acute ischemic stroke patients. At this point, we performed a comparison of accuracy among 9 predictive scores using Khon Kaen Hospital patient dataset to assess post-thrombolytic sICH risk.
     Methods: Retrospective analytic study of accuracy of predictive scores was conducted from January 2016 to April 2019. The acute ischemic stroke patients who received thrombolytic therapy were included. This study employed patients’ information from medical records. Each score system was then calculated. Subsequently, the comparison among these scores were performed using area under receiver operating characteristic curves (ROC). Other baseline characteristics were presented and compared by appropriate statistical methods.
     Results: Two hundred and fifty-one patients were recruited. There were 36 (14.34%) patients with post-thrombolytic intracerebral hemorrhage. Of these, 22 (8.76%) patients were symptomatic. Among 9 predictive scores for sICH, DRAGON had the highest predictive power (area under the ROC = 0.74), sensitivity (80.56%) and negative predictive value (91.40%).
     Conclusion: Currently, there is no best tool to predict post-thrombolytic ICH. From our result, DRAGON score was best predictor for sICH among others and could be applied to obtain additional information for patient management and bed occupancy consideration of stroke unit.


Download data is not yet available.


1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333: 1581-7.
2. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998; 352: 1245-51.
3. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007; 369: 275-82.
4. Strbian D, Sairanen T, Meretoja A, et al. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology. 2011; 77: 341-8.
5. Hsieh CY, Chen CH, Chen YC, et al. National survey of thrombolytic therapy for acute ischemic stroke in Taiwan 2003-2010. J Stroke Cerebrovasc Dis. 2013; 22: e620-7.
6. Salintip K, Pawut M. Factors Associated with Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy in Acute Ischemic Stroke. Thai Journal of Neurology. 2014; 30: 16-23.
7. Dharmasaroja PA, Muengtaweepongsa S, Pattaraarchachai J, et al. Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke. J Clin Neurosci. 2012; 19: 799-803.
8. Suengtaworn A, Saposnik G, Hurst C, Poungvarin N, et al. Accuracy of Clinical Risk Scores
in Predicting Post-rtPA Intracerebral Hemorrhage in a Thai Cohort. J Med Assoc Thai. 2019; 102: 540-6.
9. Lokeskrawee T, Muengtaweepongsa S, Patumanond J, et al. Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score. J Stroke Cerebrovasc Dis. 2017; 26: 2622-9.
10. Sung SF, Chen SC, Lin HJ, et al. Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis. Stroke. 2013; 44: 1561-6.
11. Li M, Wang-Qin RQ, Wang YL, et al. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models. J Stroke Cerebrovasc Dis. 2015; 24: 1235-43.
12. Ruedeerat W, Disya R, Jesada K. Comparison of predictive scores for symptomatic intracerebral hemorrhage after intravenous thrombolysis in Thai stroke patients. J Thai Stroke Soc. 2015; 14: 175.
13. Derex L, Hermier M, Adeleine P, et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry. 2005; 76: 70-5.
14. Lou M, Safdar A, Mehdiratta M, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008; 71: 1417-23.
15. Strbian D, Engelter S, Michel P, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol. 2012; 71: 634-41.
16. Wang A, Pednekar N, Lehrer R, et al. DRAGON score predicts functional outcomes in acute ischemic stroke patients receiving both intravenous tissue plasminogen activator and endovascular therapy. Surg Neurol Int. 2017; 8: 149.
17. Strbian D, Michel P, Seiffge DJ, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: comparison of prediction scores. Stroke. 2014; 45: 752-8.
18. Watson-Fargie T, Dai D, MacLeod MJ, et al. Comparison of predictive scores of symptomatic intracerebral haemorrhage after stroke thrombolysis in a single centre. J R Coll Physicians Edinb. 2015; 45: 127-32.
19. Asuzu D, Nystrom K, Amin H, et al. Comparison of 8 scores for predicting symptomatic intracerebral hemorrhage after IV thrombolysis. Neurocrit Care. 2015; 22: 229-33.
20. Mazya M, Egido JA, Ford GA, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012; 43: 1524-31.
21. Cucchiara B, Tanne D, Levine SR, et al. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2008; 17: 331-3.
22. Flint AC, Faigeles BS, Cullen SP, et al. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA. Stroke. 2013; 44: 3365-9.
23. Flint AC, Gupta R, Smith WS, et al. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. Int J Stroke. 2014; 9: 705-10.
24. Saposnik G, Guzik AK, Reeves M, et al. Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology. 2013; 80: 21-8.
25. Menon BK, Saver JL, Prabhakaran S, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012; 43: 2293-9.
How to Cite
Kunadison S, Nganwai R. Comparison of Accuracy among Post-thrombolytic Symptomatic Intracerebral Hemorrhage Predictive Scores in Ischemic Stroke Patients in Khon Kaen Hospital. J Thai Stroke Soc [Internet]. 2020Dec.28 [cited 2021Mar.3];19(3):17. Available from:
Original article